| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 12/13/2007 | CA2655225A1 Benzimidazoles and their use for the treatemnt of diabetes |
| 12/13/2007 | CA2653787A1 Composition for preventing the occurrence of cardiovascular event in multiple risk patient |
| 12/13/2007 | CA2652989A1 Derivatized insulin oligomers |
| 12/12/2007 | EP1864986A1 Pyrazolopyrimidine derivative or pharmaceutically acceptable salt thereof |
| 12/12/2007 | EP1864975A2 Novel compounds |
| 12/12/2007 | EP1864971A1 Prophylactic/therapeutic agent for diabetes |
| 12/12/2007 | EP1864967A1 Method for preparing O-desmethyl-venlafaxine |
| 12/12/2007 | EP1864680A2 Combinations of peroxisome proliferator-activated receptor (PPAR) activator(s) and sterol absorption inhibitor(s) and treatments for vascular indications |
| 12/12/2007 | EP1864672A1 Appetite-suppressing agent and air-conditioning apparatus for dieting |
| 12/12/2007 | EP1864670A1 Sucrase activity inhibitor, glucoamylase activity inhibitor and food and feed containing the same |
| 12/12/2007 | EP1864659A1 Lignane compound-containing oil-in-water emulsion and composition comprising the same |
| 12/12/2007 | EP1863817A1 Substituted, bicyclic 8-pyrrolidino-benzimidazoles, method for their production and their use as medicaments |
| 12/12/2007 | EP1863812A1 Dipeptidyl peptidase-iv inhibiting compounds, methods of preparing the same, and pharmaceutical compositions containing the same as an active agent |
| 12/12/2007 | EP1863801A2 Benzimidazole derivative and use thereof |
| 12/12/2007 | EP1863798A1 Indole derivatives |
| 12/12/2007 | EP1863790A1 Amide-substituted 8-n-benzimidazoles, method for the production thereof, and use of the same as medicaments |
| 12/12/2007 | EP1863789A1 Aminocarbonyl-substituted 8-n-benzimidazoles, method for their production and their use as medicaments |
| 12/12/2007 | EP1863772A1 Amide derivatives as ppar activators |
| 12/12/2007 | EP1863570A1 A synergistically heat stable oil media having eicosa pentaenoic acid (epa) and docosa hexaenoic acid (dha) |
| 12/12/2007 | EP1863537A2 Dimeric peptide agonists of the glp-1 receptor |
| 12/12/2007 | EP1863489A1 Pharmaceutical compositions containing a combination of a cannabinoid receptor antagonist compound and an antipsychotic agent |
| 12/12/2007 | EP1863488A2 Use of amino-substituted 8-n-benzimidazoles |
| 12/12/2007 | EP1863480A1 Compounds having immunomodulator activity |
| 12/12/2007 | EP1863479A1 Tetrahydrothiopyrano pyrazole cannabinoid modulators cross reference to related applications |
| 12/12/2007 | EP1863467A2 Combination of organic compounds |
| 12/12/2007 | EP1863465A1 Compositions for oral transmucosal delivery of metformin |
| 12/12/2007 | EP1718602A4 Therapeutic and carrier molecules |
| 12/12/2007 | EP1644357B1 Trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto |
| 12/12/2007 | EP1500656B1 Biguanide derivatives and their use as antidiabetic drugs |
| 12/12/2007 | EP1474414B1 Dihydro-thia-phenanthrene-carbonyl-guanidines, method for the production thereof, use thereof as a medicament or diagnostic reagent |
| 12/12/2007 | EP1432803B1 Fragments of the human zn-alpha2-glycoprotein and their use in methods of treatment of obesity |
| 12/12/2007 | EP1416942B1 Amine polymers for treating gout and binding uric acid |
| 12/12/2007 | EP1320356B1 Preparation of vitamin emulsions and concentrates thereof |
| 12/12/2007 | EP1276738B1 2-amino-3-(alkyl)-pyrimidone derivatives as gsk3.beta. inhibitors |
| 12/12/2007 | EP1268481B1 Kinase inhibitors as therapeutic agents |
| 12/12/2007 | EP1255456B1 Use of glutamate or of glutamic acid for the prevention of hyperpermeability or undesired permeability of the intestinal wall |
| 12/12/2007 | EP1237859B1 Use of bis-sulfonamides for producing medicaments used for preventing or treating hyperlipidaemia |
| 12/12/2007 | EP1148779B1 Expression of secreted human alpha-fetoprotein in transgenic animals |
| 12/12/2007 | EP1144454B1 Modified peptides as therapeutic agents |
| 12/12/2007 | EP1107988B1 Method for chromatographically purifying insulins |
| 12/12/2007 | CN101087754A Novel cyclohexane derivatives |
| 12/12/2007 | CN101087598A Solid preparation containing reduced coenzyme Q10 and method for producing the same |
| 12/12/2007 | CN101085772A Compound with PPARgamma excitant activity and application thereof |
| 12/12/2007 | CN101085743A Fluorine-containing alkoxy combretastatin derivative, preparation method and use thereof |
| 12/12/2007 | CN101085345A High mannose proteins and methods of making high mannose proteins |
| 12/12/2007 | CN101085342A Method of detecting rhCNTF medicament activity by normal rat weight loss method |
| 12/12/2007 | CN101085330A Oral administration traditional Chinese medicine composition for treating hyperlipoidemia |
| 12/12/2007 | CN101085329A Traditional Chinese medicine healthy prescription capable of tonifying kidney and enlivening spleen |
| 12/12/2007 | CN101085298A Medicine for preventing and curing diabetes and preparation method thereof |
| 12/12/2007 | CN101085292A Traditional Chinese herb pill for treating diabetes mellitus |
| 12/12/2007 | CN101085233A Civil Chinese medicinal herb with hypotensive, antilipemic and hypoylycemic function |
| 12/12/2007 | CN101085166A 复合型高儿茶素茶多酚制剂及其制备方法 Composite high catechin polyphenols and its preparation method |
| 12/12/2007 | CN101085121A Traditional Chinese medicine composition with hypoglycemic and antilipemic function and making method and application |
| 12/12/2007 | CN101085105A External applied medicine for treating cervical vertebra disease, femoral head necrosis and diabetic foot |
| 12/12/2007 | CN101085079A Traditional Chinese medicine compound for treating diabetes and its preparation method and application |
| 12/12/2007 | CN101085072A Sustained-release tablet containing folium crataegi total flavone |
| 12/12/2007 | CN101085068A 'Shengtangping' capsule for treating type II diabetes and its making method |
| 12/12/2007 | CN101085041A Total alkaloid of lotus leaves extraction and its preparation method |
| 12/12/2007 | CN101085039A Composition for preventing and treating diabetes (hyperglycaemia) and its preparation method |
| 12/12/2007 | CN101084984A Porridge with intestines-moistening and eyesight-improving function |
| 12/12/2007 | CN101084971A Method for preparing total saponins of platycodon grandiflorum |
| 12/12/2007 | CN101084945A Olive leaves extraction and preparation method thereof |
| 12/12/2007 | CN101084943A Method for preparing mixture containing natural vitamin P from sea-buckthorn |
| 12/12/2007 | CN101084941A Abelmoschus manihot health care soft opaque capsule |
| 12/12/2007 | CN101084940A Abelmoschus manihot health care soft capsule |
| 12/12/2007 | CN101084939A Abelmoschus manihot health care hard capsule |
| 12/12/2007 | CN101084937A Ginkgo leaves freezing-dried powder injection and preparation method thereof |
| 12/12/2007 | CN101084934A Liquid capsule of lucidum spore oil and preparation method |
| 12/12/2007 | CN101084932A Health-care spinulina food |
| 12/12/2007 | CN101084919A Potassium iodide sustained-release preparation and preparation method thereof |
| 12/12/2007 | CN101084918A Method for preparing selenium nutrient solution |
| 12/12/2007 | CN101084907A Voglibose dispersion tablet |
| 12/12/2007 | CN101084885A Two sustained-release preparations containing cinnamic acid for preventing coxsackie virus and preparation technology thereof |
| 12/12/2007 | CN101084880A Biological solid dispersion of vitamin E esters derivatives and preparation method thereof |
| 12/12/2007 | CN101084774A Method for preparing sugar-free natural health beverage |
| 12/12/2007 | CN100354306C GLP-1 derivatives and transmicosal absorption preparations thereof |
| 12/12/2007 | CN100354292C Novel flavonoids |
| 12/12/2007 | CN100354291C Novel natural drug effective region |
| 12/12/2007 | CN100353998C Application of combination of cytokine and hypoglycemic in treatment of diabetes |
| 12/12/2007 | CN100353983C Chinese medicine preparation for reducing sugar |
| 12/12/2007 | CN100353974C Composition of active ingredients of alisma rhizome, and medical application |
| 12/12/2007 | CN100353948C Prescription for treating type 2 diabetes and its preparing method |
| 12/12/2007 | CN100353936C Ferulaic acid sodium transfusion and prescription and preparation thereof |
| 12/11/2007 | US7307164 β-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
| 12/11/2007 | US7307102 Administering selective estrogen receptor modulators that possesses tissue-specific ER agonist activity |
| 12/11/2007 | US7307090 Piperidine derivatives useful as modulators of chemokine receptor activity |
| 12/11/2007 | US7307080 Nuclear enzyme poly(adenosine 5'-diphospho-ribose) polymerase inhibitors; protection against ill effects of reactive free radicals and nitric oxide |
| 12/11/2007 | US7307058 Multimeric Apo A-I agonist compounds |
| 12/11/2007 | US7306922 Human and rat PGC-3, PPAR-gamma coactivations and splice variants thereof |
| 12/11/2007 | US7306920 Gene associated with regulation of energy balance, obesity and diabetes and uses therefor |
| 12/11/2007 | US7306794 Methods and compositions for the treatment of defects in lipoprotein metabolism |
| 12/11/2007 | US7306782 Method for the production of conjugates and uses thereof for the prevention and treatment of allergic reactions and autoimmune diseases |
| 12/11/2007 | CA2420766C Trace elements |
| 12/11/2007 | CA2405822C Infant formulas containing long-chain polyunsaturated fatty acids and uses thereof |
| 12/11/2007 | CA2348735C Heterocyclic potassium channel inhibitors |
| 12/11/2007 | CA2348245C Treatment of rumen acidosis with .alpha.-amylase inhibitors |
| 12/11/2007 | CA2166003C Method for providing nutrition to the elderly patients |
| 12/06/2007 | WO2007140183A1 Fxr agonists |
| 12/06/2007 | WO2007140174A2 Compounds and methods for modulating fxr |
| 12/06/2007 | WO2007139948A2 Imidazoazepinone compounds |